Understanding MVID

Explore this site to learn about MVID, patient resources, our research and future work towards a new therapy.

What is MVID

New research and comprehensive resources for patients with microvillus inclusion disease

Microvillus inclusion disease (MVID) is a rare, genetic disease that causes chronic diarrhea in young babies. The amount of diarrhea often exceeds that of cholera, and infants will die unless they are given appropriate and often massive amounts of intravenous fluid. Patients with MVID often survive solely on IV fluids, also known as total parenteral nutrition or TPN, or they must undergo a small bowel transplant. Learn more about MVID.

At Vanessa Research we have patented and will soon begin clinical trials of a drug that has been developed to treat MVID – a treatment that will eliminate life-threatening diarrhea by encouraging immature cells in the intestine to grow normally and restore the absorption of fluids and nutrients. Learn more about our research.

New White Paper available now

Addressing the Microvillus Inclusion Disease Knowledge Gap

A Comprehensive Case Analysis Read more

Learn more about
our research.

May 8, 2019 - Hamden, Connecticut
Vanessa Research Interviews with Health Professional Radio to Highlight a Rare, Genetic Disease

Vanessa Research brings awareness of Microvillus Inclusion Disease to healthcare professionals worldwide HAMDEN, CT, May 8, 2019 — Vanessa Research, Inc. (VRI) — a biomedical company transforming the healthcare landscape by developing and commercializing innovative products in areas of unmet medical needs — participated in an interview with Health Professional Radio (HPR), a health-dedicated media…

Read more
April 5, 2019 - Hamden, Connecticut
Vanessa Research Announces Silver Sponsorship of The European Society for Developmental, Perinatal and Paediatric Pharmacology

Vanessa Research brings cutting-edge science to the world-renowned pediatric congress Vanessa Research, Inc. (VRI) — a biomedical company that is transforming the healthcare landscape through the development of innovative products and solutions in areas of unmet medical needs — announced it will be a silver sponsor of the 17th Congress of the European Society for…

Read more
January 17, 2019 - Hamden, Connecticut
MVID Screening Test Project Selected to Participate in the 2019 Cohort of the Accelerator for Biosciences in Connecticut

Hamden, CT – Vanessa Research, Inc. (VRI) is pleased to announce that its MIDA™ (Microvillus Inclusion Disease Assay) project, under the direction of Dr. Ludmila Kvochina, has been accepted into the 2019 cohort of the highly selective Accelerator for Biosciences in Connecticut (ABCT). MIDA™ is the first-ever dipstick test developed to screen for the incredibly…

Read more